Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Transition to chronic pain: opportunities for novel therapeutics.

Price TJ, Basbaum AI, Bresnahan J, Chambers JF, De Koninck Y, Edwards RR, Ji RR, Katz J, Kavelaars A, Levine JD, Porter L, Schechter N, Sluka KA, Terman GW, Wager TD, Yaksh TL, Dworkin RH.

Nat Rev Neurosci. 2018 Jul;19(7):383-384. doi: 10.1038/s41583-018-0012-5. No abstract available.

2.

Multidimensional Diagnostic Criteria for Chronic Pain: Introduction to the ACTTION-American Pain Society Pain Taxonomy (AAPT).

Dworkin RH, Bruehl S, Fillingim RB, Loeser JD, Terman GW, Turk DC.

J Pain. 2016 Sep;17(9 Suppl):T1-9. doi: 10.1016/j.jpain.2016.02.010. Review.

PMID:
27586826
3.

Postoperative pain documentation 30 years after.

Curatolo M, Gordon D, Terman GW.

Scand J Pain. 2016 Apr;11:125-126. doi: 10.1016/j.sjpain.2016.01.007. Epub 2016 Feb 8. No abstract available.

PMID:
28850451
4.

Ventilation and the Response to Hypercapnia after Morphine in Opioid-naive and Opioid-tolerant Rats.

Emery MJ, Groves CC, Kruse TN, Shi C, Terman GW.

Anesthesiology. 2016 Apr;124(4):945-57. doi: 10.1097/ALN.0000000000000997.

PMID:
26734964
5.

Postoperative opioid-induced respiratory depression: a closed claims analysis.

Lee LA, Caplan RA, Stephens LS, Posner KL, Terman GW, Voepel-Lewis T, Domino KB.

Anesthesiology. 2015 Mar;122(3):659-65. doi: 10.1097/ALN.0000000000000564.

PMID:
25536092
6.

Intense focused ultrasound stimulation can safely stimulate inflamed subcutaneous tissue and assess allodynia.

McClintic AM, Garcia JB, Gofeld M, Kliot M, Kucewicz JC, Loeser JD, Pederson KD, Sparks RE, Terman GW, Tych RE, Mourad PD.

J Ther Ultrasound. 2014 Feb 25;2:8. doi: 10.1186/2050-5736-2-8. eCollection 2014.

7.

Neuropathic tissue responds preferentially to stimulation by intense focused ultrasound.

Tych RE, Gofeld M, Jarvik JG, Kliot M, Loeser JD, McClintic AM, Ollos RJ, Pederson KD, Sparks RE, Terman GW, Mourad PD.

Ultrasound Med Biol. 2013 Jan;39(1):111-6. doi: 10.1016/j.ultrasmedbio.2012.08.012.

8.

Ultra-low dose ketamine and memantine treatment for pain in an opioid-tolerant oncology patient.

Grande LA, O'Donnell BR, Fitzgibbon DR, Terman GW.

Anesth Analg. 2008 Oct;107(4):1380-3. doi: 10.1213/ane.0b013e3181733ddd.

PMID:
18806055
9.

Decreased substance P and NK1 receptor immunoreactivity and function in the spinal cord dorsal horn of morphine-treated neonatal rats.

Thomson LM, Terman GW, Zeng J, Lowe J, Chavkin C, Hermes SM, Hegarty DM, Aicher SA.

J Pain. 2008 Jan;9(1):11-9. Epub 2007 Oct 24.

10.

Primary afferent NMDA receptors increase dorsal horn excitation and mediate opiate tolerance in neonatal rats.

Zeng J, Thomson LM, Aicher SA, Terman GW.

J Neurosci. 2006 Nov 15;26(46):12033-42.

11.
12.
13.

APS position statement on the use of placebos in pain management.

Sullivan M, Terman GW, Peck B, Correll DJ, Rich B, Clark WC, Latta K, Lebovits A, Gebhart G; American Pain Society Ethics Committee.

J Pain. 2005 Apr;6(4):215-7.

PMID:
15820908
14.

Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance.

Xu M, Petraschka M, McLaughlin JP, Westenbroek RE, Caron MG, Lefkowitz RJ, Czyzyk TA, Pintar JE, Terman GW, Chavkin C.

J Neurosci. 2004 May 12;24(19):4576-84.

15.

G-protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal.

Terman GW, Jin W, Cheong YP, Lowe J, Caron MG, Lefkowitz RJ, Chavkin C.

Br J Pharmacol. 2004 Jan;141(1):55-64. Epub 2003 Dec 8.

16.

Mu opiates inhibit long-term potentiation induction in the spinal cord slice.

Terman GW, Eastman CL, Chavkin C.

J Neurophysiol. 2001 Feb;85(2):485-94.

17.

Mu opioid analgesia and analgesic tolerance in two mouse strains: C57BL/6 and 129/SvJ.

Varnado-Rhodes Y, Gunther J, Terman GW, Chavkin C.

Proc West Pharmacol Soc. 2000;43:15-7. No abstract available.

PMID:
11056944
18.

Opioid modulation of recurrent excitation in the hippocampal dentate gyrus.

Terman GW, Drake CT, Simmons ML, Milner TA, Chavkin C.

J Neurosci. 2000 Jun 15;20(12):4379-88.

19.
20.

John C. Liebeskind (1935-1997): a tribute.

Terman GW.

Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):7631-4. No abstract available.

21.

Administered and endogenously released kappa opioids decrease pilocarpine-induced seizures and seizure-induced histopathology.

Bausch SB, Esteb TM, Terman GW, Chavkin C.

J Pharmacol Exp Ther. 1998 Mar;284(3):1147-55.

PMID:
9495877
23.

Kappa opioid receptor tolerance in the guinea pig hippocampus.

Jin W, Terman GW, Chavkin C.

J Pharmacol Exp Ther. 1997 Apr;281(1):123-8.

PMID:
9103488
24.

A multidimensional comparison of morphine and hydromorphone patient-controlled analgesia.

Rapp SE, Egan KJ, Ross BK, Wild LM, Terman GW, Ching JM.

Anesth Analg. 1996 May;82(5):1043-8.

PMID:
8610865
25.
26.

Inhibition of glutamate release by presynaptic kappa 1-opioid receptors in the guinea pig dentate gyrus.

Simmons ML, Terman GW, Drake CT, Chavkin C.

J Neurophysiol. 1994 Oct;72(4):1697-705.

PMID:
7823095
27.
28.

Dynorphin opioids present in dentate granule cells may function as retrograde inhibitory neurotransmitters.

Drake CT, Terman GW, Simmons ML, Milner TA, Kunkel DD, Schwartzkroin PA, Chavkin C.

J Neurosci. 1994 Jun;14(6):3736-50.

29.
30.

A case of opiate-insensitive pain: malignant treatment of benign pain.

Terman GW, Loeser JD.

Clin J Pain. 1992 Sep;8(3):255-9.

PMID:
1421740
31.

Effects of a single administration of morphine or footshock stress on natural killer cell cytotoxicity.

Shavit Y, Martin FC, Yirmiya R, Ben-Eliyahu S, Terman GW, Weiner H, Gale RP, Liebeskind JC.

Brain Behav Immun. 1987 Dec;1(4):318-28.

PMID:
3453207
32.
33.

Potentiation of pentobarbital sleeping time by the acute and chronic administration of morphine.

Pechnick RN, Terman GW, Liebeskind JC.

NIDA Res Monogr. 1987;76:233-9. No abstract available.

PMID:
2830520
34.

Involvement of brain opiate receptors in the immune-suppressive effect of morphine.

Shavit Y, Depaulis A, Martin FC, Terman GW, Pechnick RN, Zane CJ, Gale RP, Liebeskind JC.

Proc Natl Acad Sci U S A. 1986 Sep;83(18):7114-7.

35.

Effects of footshock stress and morphine on natural killer lymphocytes in rats: studies of tolerance and cross-tolerance.

Shavit Y, Terman GW, Lewis JW, Zane CJ, Gale RP, Liebeskind JC.

Brain Res. 1986 May 7;372(2):382-5.

PMID:
3011211
36.

Opioid and non-opioid stress analgesia from cold water swim: importance of stress severity.

Terman GW, Morgan MJ, Liebeskind JC.

Brain Res. 1986 Apr 30;372(1):167-71.

PMID:
3708354
37.

Two opioid forms of stress analgesia: studies of tolerance and cross-tolerance.

Terman GW, Lewis JW, Liebeskind JC.

Brain Res. 1986 Mar 12;368(1):101-6.

38.

Relation of stress-induced analgesia to stimulation-produced analgesia.

Terman GW, Liebeskind JC.

Ann N Y Acad Sci. 1986;467:300-8. Review. No abstract available.

PMID:
3524382
39.

Analgesic, locomotor and lethal effects of morphine in the mouse: strain comparisons.

Moskowitz AS, Terman GW, Carter KR, Morgan MJ, Liebeskind JC.

Brain Res. 1985 Dec 30;361(1-2):46-51.

PMID:
4084809
40.

Differential effects of scopolamine on 3 forms of stress analgesia.

Terman GW, Liebeskind JC.

Brain Res. 1985 Dec 30;361(1-2):405-7.

PMID:
4084808
41.

Stimulation-produced and stress-induced analgesia: cross-tolerance between opioid forms.

Terman GW, Penner ER, Liebeskind JC.

Brain Res. 1985 Dec 23;360(1-2):374-8.

PMID:
4075178
42.

Stress-induced analgesia in the mouse: strain comparisons.

Moskowitz AS, Terman GW, Liebeskind JC.

Pain. 1985 Sep;23(1):67-72.

PMID:
4058929
43.

Stress, opioid peptides, the immune system, and cancer.

Shavit Y, Terman GW, Martin FC, Lewis JW, Liebeskind JC, Gale RP.

J Immunol. 1985 Aug;135(2 Suppl):834s-837s.

PMID:
2989372
44.

Blockade of tolerance to morphine analgesia by pentobarbital.

Terman GW, Pechnick RN, Liebeskind JC.

Proc West Pharmacol Soc. 1985;28:157-60. No abstract available.

PMID:
4070241
45.

Involvement of opioid peptides in the analgesic, immunosuppressive, and tumor-enhancing effects of stress.

Lewis JW, Shavit Y, Terman GW, Nelson LR, Martin FC, Gale RP, Liebeskind JC.

Psychopharmacol Bull. 1985;21(3):479-84. No abstract available.

PMID:
4041060
46.

Intrinsic mechanisms of pain inhibition: activation by stress.

Terman GW, Shavit Y, Lewis JW, Cannon JT, Liebeskind JC.

Science. 1984 Dec 14;226(4680):1270-7.

PMID:
6505691
47.

Body region shocked need not critically define the neurochemical basis of stress analgesia.

Cannon JT, Terman GW, Lewis JW, Liebeskind JC.

Brain Res. 1984 Dec 10;323(2):316-9.

PMID:
6525518
48.

Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity.

Shavit Y, Lewis JW, Terman GW, Gale RP, Liebeskind JC.

Science. 1984 Jan 13;223(4632):188-90.

PMID:
6691146
49.

The effects of corticosterone on opioid stress analgesia.

Terman GW, Lewis JW, Liebeskind JC.

Proc West Pharmacol Soc. 1984;27:447-50. No abstract available.

PMID:
6093139
50.

Apparent involvement of opioid peptides in stress-induced enhancement of tumor growth.

Lewis JW, Shavit Y, Terman GW, Nelson LR, Gale RP, Liebeskind JC.

Peptides. 1983 Sep-Oct;4(5):635-8.

PMID:
6686324

Supplemental Content

Loading ...
Support Center